Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Other Non Operating Income: 2017-2024

Historic Other Non Operating Income for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $862,000.

  • Puma Biotechnology's Other Non Operating Income fell 66.86% to $115,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 6.72%. This contributed to the annual value of $862,000 for FY2024, which is 13.57% up from last year.
  • As of FY2024, Puma Biotechnology's Other Non Operating Income stood at $862,000, which was up 13.57% from $759,000 recorded in FY2023.
  • Puma Biotechnology's Other Non Operating Income's 5-year high stood at $22.7 million during FY2021, with a 5-year trough of -$28,000 in FY2022.
  • Moreover, its 3-year median value for Other Non Operating Income was $759,000 (2023), whereas its average is $531,000.
  • Per our database at Business Quant, Puma Biotechnology's Other Non Operating Income slumped by 100.12% in 2022 and then soared by 2,810.71% in 2023.
  • Yearly analysis of 5 years shows Puma Biotechnology's Other Non Operating Income stood at $13.7 million in 2020, then soared by 66.10% to $22.7 million in 2021, then slumped by 100.12% to -$28,000 in 2022, then skyrocketed by 2,810.71% to $759,000 in 2023, then climbed by 13.57% to $862,000 in 2024.